0001181431-14-029918.txt : 20140821
0001181431-14-029918.hdr.sgml : 20140821
20140821194750
ACCESSION NUMBER: 0001181431-14-029918
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140819
FILED AS OF DATE: 20140821
DATE AS OF CHANGE: 20140821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001302573
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383572512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-995-8200
MAIL ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAKIANATHAN DEEPIKA
CENTRAL INDEX KEY: 0001270734
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35993
FILM NUMBER: 141058686
MAIL ADDRESS:
STREET 1: 3000 SAND HILL RD, BLDG 1, STE 135
STREET 2: C/O DELPHI VENTURES
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
rrd414996.xml
OMED FORM 4 PURCHASES
X0306
4
2014-08-19
0
0001302573
OncoMed Pharmaceuticals Inc
OMED
0001270734
PAKIANATHAN DEEPIKA
C/O DELPHI VENTURES
3000 SAND HILL ROAD, #1-135
MENLO PARK
CA
94025
1
0
0
0
Common Stock
2014-08-19
4
P
0
12425
18.8892
A
1924570
I
By Delphi Ventures VIII, L.P.
Common Stock
2014-08-19
4
P
0
116
18.8892
A
18310
I
By Delphi BioInvestments VIII, L.P.
Common Stock
2014-08-20
4
P
0
45630
18.9973
A
1970200
I
By Delphi Ventures VIII, L.P.
Common Stock
2014-08-20
4
P
0
429
18.9973
A
18739
I
By Delphi BioInvestments VIII, L.P.
Common Stock
2014-08-21
4
P
0
21402
18.9782
A
1991602
I
By Delphi Ventures VIII, L.P.
Common Stock
2014-08-21
4
P
0
201
18.9782
A
18940
I
By Delphi BioInvestments VIII, L.P.
The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP VIII"), the general partner of each of Delphi Ventures VIII, L.P. and Delphi BioInvestments VIII, L.P. (collectively, the "Delphi VIII Funds"). As a managing member of DMP VIII, the Reporting Person shares voting and dispositive power over the shares held by the Delphi VIII Funds and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such shares held by the Delphi VIII Funds, except to the extent of her proportionate pecuniary interest therein.
/s/ Matthew T. Potter, Attorney-in-Fact for Deepika R. Pakianathan
2014-08-21